Medical management with diazepam for electrical status epilepticus during slow wave sleep in children

Densley Francois1, Jessica Roberts1, Stephany Hess1

  • 1Upstate Golisano Children's Hospital, Upstate Medical University, Syracuse, NY.

Pediatric Neurology
|January 8, 2014
PubMed

Insights

High-dose oral diazepam effectively reduced electrical status epilepticus during slow wave sleep (ESES) in children, decreasing spike wave counts. However, some patients experienced new behavioral and neurological side effects, warranting further investigation.

Area of Science:

  • Pediatric Neurology
  • Sleep Medicine
  • Pharmacology

Background:

  • Electrical status epilepticus during slow wave sleep (ESES) is a challenging condition in children.
  • Oral diazepam is a proposed treatment, but its long-term efficacy and safety require further evaluation.

Purpose of the Study:

  • To retrospectively assess the long-term efficacy of high-dose oral diazepam in reducing electrographic and clinical signs of ESES in children.
  • To evaluate safety and behavioral outcomes in children receiving ongoing diazepam therapy for ESES.

Main Methods:

  • Retrospective analysis of demographic and clinical data from 42 children treated for ESES between 2010 and 2013.
  • Assessment of electroencephalograph (EEG) spike wave index reduction (≥50%) after high-dose oral diazepam administration.
  • Caregiver questionnaires to evaluate behavioral problems and side effects.

Main Results:

  • 69.2% of 26 evaluable children achieved >50% reduction in EEG spike wave count (average reduction from 15.54 to 5.05, P=0.001).
  • Caregiver surveys (28 responses) indicated new onset problem-solving, speech, and writing difficulties in some patients.
  • Most frequent side effects included sleep disturbances (50%) and irritability (57.1%); no dose-related effects were observed.

Conclusions:

  • High-dose oral diazepam significantly reduces EEG spike wave count in pediatric ESES.
  • While effective for EEG findings, diazepam therapy may be associated with significant neurological and behavioral side effects.
  • Further research is warranted to optimize treatment and manage adverse effects of diazepam in ESES.
Abstract

Related Concept Videos

Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
785
Sedatives and Hypnotics Drugs: Benzodiazepines01:19

Sedatives and Hypnotics Drugs: Benzodiazepines

Benzodiazepines have both sedative and hypnotic properties. They include compounds such as diazepam (Valium) and alprazolam (Xanax). Structurally, their cores are similar, consisting of the fusion of a benzene ring and a diazepine ring, but they share a common mechanism of action in the central nervous system (CNS).
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
1.5K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.7K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.4K
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
981
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K